Advisory Board
Leon Rozenblit
Leon is an entrepreneur and leader of knowledge intensive teams who seeks to use his expertise in cognitive psychology, statistics, and technology to help research organizations maximize the utility of their data. Leon founded Prometheus Research in 1999 and has grown the organization to a leading innovator in integrated data management for human-subjects research with over 50 employees. While at Prometheus, Leon has led research informatics teams that have successfully served a number of high-profile national and international projects resulting in significant scientific impact. He has also served as a principal investigator on a number of NSF and NIH grants and has overseen Data Coordinating Centers for research consortia.
Leon was born in the Russian part of the former Soviet Union in a city on the Volga river (then called Kuybyshev) that has since been renamed back to its pre-Soviet name of Samara. He lives in the East Rock neighborhood of New Haven with his wife and two children where he can walk to both the hiking trails in East Rock Park and to the Prometheus offices in downtown New Haven most days of the year. Leon holds a JD from Louisiana State University and a PhD in Psychology from Yale University.
Eleanor is CEO, Co-Founder, and Member of the Board of Directors at NovaTract Surgical, Inc., a venture-backed start-up developing instruments for laproscopic surgery. Prior to NovaTract Surgical, Inc., Ms. Tandler was the Director of Venture Development at UConn R&D; Corporation where she worked to create new business start-ups based on innovative technologies developed by the faculty and staff at the University of Connecticut. While at UConn R&D; Corporation, she served as interim CEO of New Ortho Polymers, a UConn start-up focused on the development of new orthodontic appliances utilizing high performance polymers. Prior to that, she spent five years as a venture capital investor with Radius Ventures, an early-stage venture capital firm focused on health and life sciences with about $230 million under management. Prior to Radius, Ms. Tandler was at Ernst & Young LLP in their healthcare consulting group, providing strategic and operational advisory services, primarily to healthcare and life sciences clients. Ms. Tandler received an MBA from New York University’s Stern School of Business and a BA in Economics and Mathematics from the University of Massachusetts at Amherst with honors.
Ben, a biomedical engineer turned business executive, is a Managing Director at the consulting firm Sagebrook Partners. He possesses wide-ranging and in-depth experience in new organization startups, venture financing, business and corporate development, strategic planning, university-based technology transfer, licensing, and intellectual property strategy and management. Ben founded RB Muskin, LLC in 2006 as a technology transfer / business development consulting firm to provide consulting services to colleges, universities, healthcare organizations, non-profit research institutions, as well as for-profit firms in the life sciences space. Prior to RB Muskin, LLC, Ben was Co-Founder and Vice President of Business Development and Strategic Planning of CGI Pharmaceuticals (sold to Gilead Pharmaceuticals). Prior to CGI, Ben served as Associate Director in Yale University’s Technology Transfer “Office of Cooperative Research”. During his four-year tenure at Yale, he successfully consummated dozens of license and sponsored research agreements. He also had lead responsibility for launching multiple Yale spinout companies. Earlier in Ben’s career, he was the Co-Founder and President of Spectrum Medical Technologies (licensed to DeRoyal Industries) and a project engineer / forensic engineer / and hospital consultant for ECRI Institute. Ben holds a BS in Physics/Engineering from Washington and Lee University and he pursued Master/PhD work in Biomedical Engineering at Drexel University.
